Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. (DBTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · DBTX · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Decibel Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
DBTX insider buying and selling by quarter
DBTX insider selling · DBTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
DBTX executive sell shares · DBTX board member insider trading · DBTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 25, 2023 | Trask Anna CPO | Other | 106,864 | $374K | Form 4 |
| Sep 25, 2023 | Carson William H. Director | Other | 5,000 | $18K | Form 4 |
| Sep 25, 2023 | Lee John Jui-Jen Chief Development Officer | Other | 147,144 | $515K | Form 4 |
| Sep 25, 2023 | FINGER ALISON CECILY Director | Other | 5,000 | $18K | Form 4 |
| Sep 25, 2023 | MCLAUGHLIN KEVIN F Director | Other | 5,000 | $18K | Form 4 |
| Sep 25, 2023 | Reid Laurence See Remarks · Director | Other | 220,849 | $773K | Form 4 |
| Sep 25, 2023 | Kapusta Matthew C Director | Other | 10,000 | $35K | Form 4 |
| Sep 25, 2023 | Nochur Sara Director | Other | 5,000 | $18K | Form 4 |
| Jun 13, 2023 | Nochur Sara Director | Award | 5,000 | — | Form 4 |
| Jun 13, 2023 | Carson William H. Director | Award | 5,000 | — | Form 4 |
| Jun 13, 2023 | FINGER ALISON CECILY Director | Award | 5,000 | — | Form 4 |
| Jun 13, 2023 | MCLAUGHLIN KEVIN F Director | Award | 5,000 | — | Form 4 |
| Mar 19, 2023 | Kapusta Matthew C Director | Award | 10,000 | — | Form 4 |
| Mar 16, 2023 | Reid Laurence See Remarks · Director | Award | 195,000 | — | Form 4 |
| Jan 26, 2023 | Trask Anna CPO | Award | 105,000 | — | Form 4 |
| Jan 26, 2023 | Lee John Jui-Jen Chief Development Officer | Award | 120,000 | — | Form 4 |
| Jan 3, 2022 | Trask Anna See Remarks | Sale | 1 | $5 | Form 4 |
| Jan 3, 2022 | Trask Anna See Remarks | Sale | 377 | $2K | Form 4 |
| Dec 2, 2021 | Trask Anna See Remarks | Sale | 4,913 | $31K | Form 4 |
| Dec 2, 2021 | Trask Anna See Remarks | Sale | 378 | $2K | Form 4 |
| Nov 3, 2021 | Trask Anna See Remarks | Sale | 378 | $3K | Form 4 |
| Nov 2, 2021 | Trask Anna SEE REMARKS | Sale | 4,913 | $41K | Form 4 |
| Oct 14, 2021 | Trask Anna See Remarks | Sale | 5,364 | $40K | Form 4 |
| Sep 15, 2021 | Reid Laurence President and Chief Executive · Director | Purchase | 10,000 | $76K | Form 4 |
| Feb 17, 2021 | Schroder Adveq Technology IX S.C.S. 10 percent owner | Other | 524,328 | $524 | Form 4 |
Lee John Jui-Jen
Chief Development Officer
Date
Sep 25
Shares
147,144
Price
$3.50
Value
$515K
Reid Laurence
See Remarks · Director
Date
Sep 25
Shares
220,849
Price
$3.50
Value
$773K
Lee John Jui-Jen
Chief Development Officer
Date
Jan 26
Shares
120,000
Price
—
Value
—
Reid Laurence
President and Chief Executive · Director
Date
Sep 15
Shares
10,000
Price
$7.64
Value
$76K
Schroder Adveq Technology IX S.C.S.
10 percent owner
Date
Feb 17
Shares
524,328
Price
$0.00
Value
$524
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About DBTX insider trading
DBTX insider trades
Decibel Therapeutics, Inc. (DBTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DBTX. Over the past 12 months, 0 insiders have filed transactions with the SEC. DBTX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Decibel Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
DBTX insider trading · 5 questionsThe insiders of Decibel Therapeutics, Inc. (DBTX) include executives and directors such as DBTX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026